Standout Papers

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2D6</i>, <i>CYP2C19</i>, <i>CYP2B6</i>, <i>SLC6A4</i>, an... 2023 2026 2024153
  1. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants (2023)
    Chad Bousman, James M. Stevenson et al. Clinical Pharmacology & Therapeutics

Immediate Impact

5 from Science/Nature 45 standout
Sub-graph 1 of 15

Citing Papers

A scoping review of factors influencing the implementation of liquid biopsy for cancer care
2025 Standout
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial
2024 Standout
2 intermediate papers

Works of Gillian C. Bell being referenced

Prediction of chemotherapy-induced nausea and vomiting from patient-reported and genetic risk factors
2018
Key Lessons Learned from Moffitt’s Molecular Tumor Board: The Clinical Genomics Action Committee Experience
2017

Author Peers

Author Last Decade Papers Cites
Gillian C. Bell 367 237 114 23 685
Amanda R. Elsey 452 301 156 20 740
Benjamin Staley 218 157 74 15 618
Whitney D. Maxwell 286 143 91 21 848
Holli H. Dilks 199 101 154 17 632
Jaekyu Shin 258 89 44 43 702
Kathryn M. Momary 368 45 50 37 734
Katja S. Just 137 106 104 38 631
RHN van Schaik 385 301 64 9 823
Corine Ekhart 142 109 54 35 722
Gregory L. Kearns 263 306 29 19 822

All Works

Loading papers...

Rankless by CCL
2026